Safety, tolerability, pharmacokinetics and pharmacodynamics of AZP-531, a first-in-class analogue of unacylated ghrelin, in healthy and overweight/obese subjects and subjects with type 2 diabetes

S Allas, T Delale, N Ngo, M Julien, P Sahakian, J Ritter, T Abribat, AJ (Aart-Jan) van der Lely

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)868-874
Number of pages7
JournalDiabetes Obesity & Metabolism
Volume18
Issue number9
DOIs
Publication statusPublished - 2016

Cite this